ArticlePDF Available
Diabetes mellitus is a serious metabolic disease,
affecting people of all geographic, ethnic or racial
origin and its prevalence is increasing globally1.
Burden from this costly disease is high on the low and
middle income countries (LMIC) where the impacts of
modernization and urbanization have caused marked
adverse changes in lifestyle parameters.
In 2013, of the estimated 382 million people with
diabetes globally, more than 80 per cent lived in LMIC.
It was estimated that India had 65.1 million adults with
diabetes in 2013, and had the 2nd position among the
top 10 countries with the largest number of diabetes.
This number is predicted to increase to 109 million by
2035 unless steps are taken to prevent new cases of
diabetes1. Primary prevention of diabetes is feasible
and strategies such as lifestyle modication are shown
to be effective in populations of varied ethnicity2,3.
However, for implementation of the strategies at the
population level, national programmes which are
culturally and socially acceptable and practical have
to be formulated which are currently lacking in most
of the developed and developing countries. Early
diagnosis and institution of appropriate therapeutic
measures yield the desired glycaemic outcomes and
prevent the vascular complications4.
Type 2 diabetes which accounts for 85-95 per cent
of all diabetes has a latent, asymptomatic period of
sub-clinical stages which often remains undiagnosed
for several years1. As a result, in many patients the
vascular complications are already present at the
time of diagnosis of diabetes, which is often detected
by an opportunistic testing. Asian populations in
general, particularly Asian Indians have a high risk of
developing diabetes at a younger age when compared
with the western populations5. Therefore, it is essential
that efforts are made to diagnose diabetes early so that
the long term sufferings by the patients and the societal
burden can be considerably mitigated.
Risk factors for diabetes
Many studies have shown that awareness about the
diabetes and its complications is poor among the general
population specially in the rural areas6,7. There is an
urgent need to create awareness among the population
regarding diabetes and about the serious consequences
of this chronic disorder. Epidemiological data from
India have shown the presence of a number of risk
factors which can be easily identied by simple non-
invasive risk scores8,9. The major risk factors are listed
in Box 1.
Signs and symptoms of diabetes
The signs and symptoms of diabetes are disregarded
by many because of the chronic progression of the
Indian J Med Res 140, November 2014, pp 579-581
Editorial
Know the signs and symptoms of diabetes
579
This editorial is published on the occasion of World Diabetes Day – November 14, 2014
Box 1. Major risk factors for type 2 diabetes in Indians
Positive family history of diabetes1.
Age >35 yr2.
Overweight (Body mass index ≥23 kg/m3. 2 ) and obesity
(Body mass index ≥25 kg/m2 )
Enlarged waist or upper body adiposity (>90 cm for 4.
men and >80 cm for women)
Presence of hypertension5.
Recent weight gain6.
Sedentary lifestyle7.
Gestational diabetes8.
580 INDIAN J MED RES, NOVEMBER 2014
disease. People do not consider this as a serious problem
because unlike many other diseases the consequences
of hyperglycaemia are not manifested immediately.
People are not aware that damage can start several
years before symptoms become noticeable. This is
unfortunate because recognition of early symptoms
can help to get the disease under control immediately
and to prevent vascular complications.
Warning signs & classic symptoms of diabetes
Considering the asymptomatic nature of type
2 diabetes in the early stages, it is essential that the
people are educated on its warning signs (Box 2).
The classic symptoms of diabetes such as polyuria,
polydypsia and polyphagia occur commonly in type
1 diabetes, which has a rapid development of severe
hyperglycaemia and also in type 2 diabetes with very
high levels of hyperglycaemia. Severe weight loss is
common only in type 1 diabetes or if type 2 diabetes
remains undetected for a long period. Unexplained
weight loss, fatigue and restlessness and body pain are
also common signs of undetected diabetes. Symptoms
that are mild or have gradual development could also
remain unnoticed.
Screening test for diabetes
A person of Asian origin aged 35 yr or more with
two or more of the above risk factors, should undergo
a screening test for diabetes. An oral glucose tolerance
test (OGTT) is commonly used as the screening test10.
Fasting and 2 h post glucose tests can identify impaired
fasting glucose (IFG) (fasting glucose >110 - <125
mg/dl), impaired glucose tolerance (IGT) (2 h glucose
>140-<200 mg/dl) and presence of diabetes (fasting >
126 and 2 h glucose >200 mg/dl). If a random blood
glucose value is > 150 mg/dl, further conrmation
by an OGTT is warranted. Recently, glycosylated
haemoglobin (HbA1c) has been recommended as the
test for diagnosis of diabetes (>6.5%). Presence of pre-
diabetes is indicated by HbA1c values between 5.7 - 6.4
per cent11.
Screening for undiagnosed T2DM is recommended
at the rst prenatal visit in women with above risk
factors, using standard diagnostic method criteria.
Screening for gestational diabetes (GDM) at 24-28 wk
of gestation is recommended in women who do not
have previous history of diabetes, as GDM remains
asymptomatic11. A history of GDM carries a high risk
for developing diabetes.
Signicance of identifying prediabetes
Even prediabetic stages such as IFG and IGT
carry high risk for vascular complications such as
cardiovascular diseases. The recent estimates by the
International Diabetes Federation (IDF)1 indicate that
globally there are more than 316 million people (6.9%)
with IGT. Among them, more than 70 per cent live in
LMIC1.
It is also important to note that currently one third of
those who have IGT are in the productive age between
20-39 yr and, therefore, are likely to spend many years
at high risk of developing diabetes and/or complications
of diabetes1. Some persons with prediabetes experience
reactive hypoglycaemia 2-3 hours after a meal. This
is a sign of impaired insulin metabolism indicative of
impending occurrence of diabetes. Therefore, periodic
medical check-up in people with such signs or risk
factors for diabetes would reduce the hazards involved
in having undiagnosed diabetes. It would help improve
the health status of a large number of people who
otherwise would be silent sufferers from the metabolic
aberrations associated with diabetes.
Conclusions
Awareness about the signs and symptoms and
periodic screening especially in the presence of risk
factors and warning signs of diabetes, would go a long
way in preventing new cases of diabetes by providing
an opportunity to intervene at the stage of prediabetes.
It is evident that diabetes can be prevented among
Box 2. Warning signs of diabetes
Unexplained weight loss1.
Frequent fatigue2.
Irritability3.
Repeated infections especially in the4.
Genital areas•
Urinary tract•
Skin•
Oral cavity•
Delayed wound healing•
Dry mouth5.
Burning, pain, numbness on feet6.
Itching7.
Reactive hypoglycaemia8.
Acanthoses nigricans-the presence of velvety dark 9.
patches of the neck, arm pit, groin which is an indicator
of insulin resistance
Decreased vision10.
Impotence or erectile dysfunction11.
prediabetic individuals by improvements in physical
activity and diet habits. Such strategies will also prevent
development of diabetic complications to a great extent.
Patient empowerment is vital in diabetes management.
This can be done through patient education and sharing
information on management and preventive aspects of
diabetes.
A. Ramachandran
India Diabetes Research Foundation &
Dr. A. Ramachandran’s Diabetes Hospitals
28, Marshalls Road, Egmore
Chennai 600 008, Tamil Nadu, India
ramachandran@vsnl.com
References
IDF Diabetes Atlas, 61. th ed. International Diabetes Federation,
2013. Available from: www. idf.org/diabetesatlas, accessed on
January 6, 2014.
Alberti KGMM, Zimmet P, Shaw J. International Diabetes 2.
Federation: a consensus on type 2 diabetes prevention. Diabet
Med 2007; 24 : 451-63.
Ramachandran A, Snehalatha A, Samith Shetty A, Nanditha 3.
A. Primary prevention of type 2 diabetes in South Asians-
challenges and the way forward. Diabet Med 2013; 30 :
26-34.
Abdul-Ghani MA, DeFronzo RA. Pathophysiology of 4.
prediabetes. Curr Diab Rep 2009; 9 : 193-9.
Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. 5.
Lancet 2010; 375 : 408-18.
Murugesan N, Snehalatha C, Shobhana R, Roglic G, 6.
Ramachandran A. Awareness about diabetes and its
complications in the general and diabetic population in a city
in southern India. Diabetes Res Clin Pract 2007; 77 : 433-7.
Mohan D, Raj D, Shanthirani CS, Datta M, Unwin NC, Kapur 7.
A, et al. Awareness and knowledge of diabetes in Chennai
- the Chennai urban rural epidemiology study (CURES-9).
J Assoc Physicians India 2005; 53 : 283-7.
Ramachandran A, Snehalatha C, Vijay V, Wareham NJ, 8.
Colagiuri S. Derivation and validation of diabetes risk score
for urban Asian Indians. Diabetes Res Clin Pract 2005; 70 :
63-70.
Mohan V, Anbalagan VP. Expanding role of the Madras 9.
Diabetes Research Foundation - Indian Diabetes Risk Score in
clinical practice. Indian J Endocrinol Metab 2013; 17 : 31-6.
World Health Organization. 10. Denition, diagnosis and
classication of diabetes mellitus and its complications. Report
of a WHO Consultation. Part 1: Diagnosis and classication of
diabetes mellitus. Geneva: World Health Organization; 1999.
American Diabetes Association. Standards of medical care in 11.
diabetes. Diabetes Care 2011; 34 : S11-61.
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 12.
10-year follow-up of intensive glucose control in type 2
diabetes. N Engl J Med 2008; 359 : 1577-89.
RAMACHANDRAN: KNOW THE SIGNS & SYMPTOMS OF DIABETES 581
... T2DM accounts for about 85.0%-95.0% of all patients with diabetes and is more common than T1DM [5]. Globally, in a study published (2017) about 462 million (6.3%) people were affected. ...
... T2DM has warning signs and symptoms, such as unexpected weight loss, fatigue, irritability, decreased vision and delayed wound healing. It also has classic symptoms, such as polydipsia, polyphagia and polyuria, which are also common in patients with T1DM [5]. ...
Article
Full-text available
Introduction Diabetes mellitus (DM) is a serious health condition affecting people worldwide with a high prevalence rate. DM is classified according to its aetiology into type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM); several risk factors contribute to the development of T2DM, such as age, genetic predisposition and obesity. Metformin is a proven drug of choice, and it is used as a first‐line treatment for patients with T2DM to improve their glycaemic levels. Vitamin B12 is an important water‐soluble vitamin, and its deficiency can lead to megaloblastic anaemia. Material and Methods A Cross‐sectional retrospective study was conducted on patients with T2DM in a Sedi Hussein diabetic polyclinic in Benghazi, Libya. The total sample was 381 patients: T1DM 15 (n), and T2DM 366 (n). T1DM was excluded from our results. Patients with T2DM were divided into two groups: the control group (not on metformin) consisted of 71 patients, and the group that received metformin (M group) consisted of 295 patients. Aims of the Study To assess serum vitamin B12 levels in patients with T2DM and evaluate the prevalence of vitamin B12 deficiency among those receiving metformin treatment. Results The M group significantly decreased vitamin B12 serum levels by 443.56 mg/mL versus the control group of 541.33 pg/mL (p = 0.003). The prevalence of patients with vitamin B12 deficiency under the metformin treatment was 23.84%. There was no significant difference in correlation between serum vitamin B12 levels and both doses of metformin and the duration of diabetes mellitus. Conclusion Vitamin B12 was significantly decreased in patients with T2DM receiving metformin.
... This is undesirable because early detection of symptoms can help prevent vascular issues and expedite the management of the condition. (20)  ...
... The prevalence of DM seems to be higher amongst the elderly population aged 60 years of age and above [8], particularly in low-and middle-income countries (LMICs) such as China, India, and Sub-Saharan countries [9,10]. While DM is growing worldwide, the prevalence of diabetes seems to be higher in the elderly population compared to the younger generation [11]. The risk of developing DM is particularly increased in adults aged 60 years of age and older due to a variety of factors that include genetic makeup, a long-life expectancy that causes a decrease in insulin secretion, and other lifestyle choices that contribute to central obesity [12,13]. ...
Article
Full-text available
Diabetes mellitus (DM) is a common chronic health condition, affecting millions of people worldwide, and its incidence is projected to increase by almost 50% in the next two decades. The effects of DM on the auditory system have been reported. However, there is limited evidence on the association between DM and middle ear pathologies. This scoping review aimed to map the available evidence and identify research gaps regarding DM and middle ear pathologies in the adult population. Five electronic databases, namely Scopus, CINAHL, MEDLINE, PubMed, and Web of Science, were searched using a combination of specific key terms. This review followed the guidelines stipulated by the Joanna Briggs Institute (JBI) methodology for scoping reviews and reporting using PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. A thematic narrative analysis was used to synthesize key findings. Of the 1809 articles, only 2 articles met the inclusion criteria. Neither of these studies focused exclusively on middle ear pathologies in DM, but they did report incidental findings related to middle ear function. Available evidence suggests that middle ear pathologies may occur in individuals with DM, with a reported prevalence ranging from 3.1% to 19.6%. Otitis media with effusion and conductive hearing loss were common middle ear pathologies identified. Additionally, recent studies have provided new evidence suggesting ossicular joint changes in individuals with DM and a causal link between DM and acute suppurative otitis media. However, age-related hearing loss (presbycusis) and sensorineural hearing loss (SNHL) were more commonly associated with DM, with studies reporting a high prevalence of SNHL in younger to middle-aged adults with diabetes. This review highlights a significant research gap in the literature, as no studies directly investigated the relationship between DM and middle ear function as a primary focus. Further research is required to investigate this potential association using methodologies explicitly designed for middle ear assessment. While some evidence suggests a possible association, the lack of age-stratified analyses, imaging data, and comprehensive diagnostic testing limits the ability to draw strong conclusions. Further research incorporating age-based analyses, radiological assessments, and microbiome studies is needed to fully understand the potential impact of DM on middle ear health.
... The healing process is slowed down by poor circulation, which lowers the wound's availability of oxygen and nutrients. [22] [23] Gestational diabetes mellitus signs and symptoms: -Gestational diabetes typically shows no overt symptoms. However, some women make experience is some symptoms such as ...
... In diabetic patients, long-term complications may involve retinopathy, potentially leading to vision lss; nephropathy, which can result in kidney failure; peripheral neuropathy, increasing the likelihood of Charcot joints, foot ulcers, and amputations; and autonomic neuropathy, which may cause symptoms affecting the gastrointestinal, cardiovascular, and sexual systems and genitourinary as well as infertility. Additionally, cardiovascular, cerebrovascular, atherosclerotic, peripheral, and arterial disorders are more common in these people (Boon et al., 2006;Lodhi, 2021;Ramachandran, 2014). ...
Article
Full-text available
Diabetes mellitus, characterized by hyperglycemic symptoms, has emerged as a major global health challenge. The disease's severity is compounded by both micro and macro vascular complications associated with hyperglycemia, leading to significant morbidity. Current conventional anti-diabetic medications, while widely prescribed, often demonstrate high failure rates and are associated with adverse pathological effects.
... (Wicklow, 2023) Diabetes is generally characterized by a group of symptoms, which include increased thirst, dry lips, excessive urination, exhaustion, lightheadedness, inexplicable weight loss, tingling sensation or numbness in your hands or feet, and wounds or sores that take a long time to heal and return to healthy and normal conditions, recurrent skin and/or vaginal yeast infections and other symptoms that appear after suffering from all three types of diabetes. (Ramachandran, 2021) ...
Article
Full-text available
Type one diabetic is a major metabolic disease that effect on children It is distinguished by increase glucose level in blood result of insulin secretion defect, It can be diagnosis by plasma glucose intolerance, HbA1c and fasting blood glucose. It lead to a major complications as blindness, amputation, etc. The study objectives are to identify parent's knowledge towards diabetic children and to find-out the relationship between parent's knowledge and socio-demographic characteristic. Material and method A quasi experimental study is carried to describe effectiveness of the educational program upon parents knowledges toward your diabetic children care in the diabetic and endocrine center of Al-Najaf Al-Ashraf city by use the method of pretest/ posttest 1 then posttest 2 by application it on both study group and control group for the period of july.28/ 2024 until October. 10/2024. Study Results: Finding revealed parents knowledge level of study group altered significantly (P<0.05), where before performing educational program sessions the knowledge mean was (1.18) then became after the application of educational program sessions (1.65) and in post-test two the mean became (1.66), while the parents knowledge in control group stayed the same without any change. the research explained the major children age group in both groups with (6-10 years). The parents knowledge in experimental group in posttest1 &2 is elevating, this indicated the educational program was effective interventional approach to improve parents knowledge. Also finding refer to a scientific association between parent knowledge and demographic data in disease period, father and mother Educational level
... In diabetic patients, long-term complications may involve retinopathy, potentially leading to vision lss; nephropathy, which can result in kidney failure; peripheral neuropathy, increasing the likelihood of Charcot joints, foot ulcers, and amputations; and autonomic neuropathy, which may cause symptoms affecting the gastrointestinal, cardiovascular, and sexual systems and genitourinary as well as infertility. Additionally, cardiovascular, cerebrovascular, atherosclerotic, peripheral, and arterial disorders are more common in these people (Boon et al., 2006;Lodhi, 2021;Ramachandran, 2014). ...
Article
Full-text available
Background: Diabetes mellitus, characterized by hyperglycemic symptoms, has emerged as a major global health challenge. The disease’s severity is compounded by both micro- and macrovascular complications associated with hyperglycemia, leading to significant morbidity. Current conventional anti-diabetic medications, while widely prescribed, often demonstrate high failure rates and are associated with adverse pathological effects. Purpose: This paper aims to evaluate the potential of polyherbal formulations in the treatment of diabetes mellitus, addressing the need for alternative therapeutic approaches with enhanced efficacy and reduced side effects. Methods: The study examines various natural extracts and their constituents derived from medicinal plants, focusing on their hypoglycemic properties. Special attention is given to polyherbal formulations, which combine multiple herbs to potentially enhance therapeutic efficacy while reducing individual herb concentrations and associated adverse effects. Results: While numerous herbal medications have been developed for diabetes mellitus treatment, the review identifies a significant gap in scientific validation and medical proof of their efficacy. Polyherbal formulations show promise in enhancing therapeutic action while minimizing adverse events through reduced concentrations of individual herbs. Conclusion: The investigation highlights the potential of polyherbal formulations as an alternative approach to diabetes management. However, there is a crucial need for rigorous scientific validation and clinical trials to establish their efficacy and safety profiles before widespread implementation in diabetes treatment protocols.
... People with type 1 diabetes can receive life-saving and ongoing care from insulin therapy. The self-management plan for a person with type 1 diabetes must include insulin delivery, blood glucose monitoring, physical activity, and a healthy diet (Bjornstad P et al., 2018;Ramachandran, A. 2014). Hyperglycemia in type 2 diabetes is caused by the body's cells' failure to respond adequately to insulin, a condition known as 'insulin resistance.' Insulin resistance causes the hormone to be inefficient, which eventually leads to an increase in insulin production ( Gestational diabetes mellitus is described as glucose intolerance that develops during pregnancy; the prevalence of gestational diabetes and type 2 diabetes is increasing globally, resulting in significant healthcare and economic consequences (Health Direct, 2024). ...
Article
Full-text available
Piper betle is an evergreen plant that has been claimed to possess various therapeutic properties including diabetes for a long period of time. The present study was undertaken to evaluate the antidiabetic effects of Piper betle (100% methanolic extract) on neonatal streptozotocin (nSTZ) induced type 2 diabetic (T2DM) model rats. P. betle methanolic extract preparation and phytochemicals screening test were done by following standard methods. Diabetes was induced in 48hrs rat pups by a single ip injection of STZ (90mg/kg bw). After three months, OGTT was done (glucose 2.5g/10ml/kg bw) to find out their glycemic status. Six normal and 18 T2DM Long Evans rats were chosen and divided them into four groups. Where group (i) was comprised of normal rats i) Normal water control (NWC); ii) Diabetic water Control (DWC), iii) Gliclazide (GT 20mg/5ml/kg bw) and iv) P. betle (1.25g/10ml/kg bw) extract treated groups respectively. In 28 days, experimental period groups (i) and (ii) received water orally (10ml/kg bw) respectively with a single feeding. 24 Blood samples were collected at the beginning by tail cut and cardiac puncture method was done at the end of the study under halothane anesthesia. Blood serum and dissected small portion of the liver were stored at-20˚C refrigerator for biochemical (fasting serum glucose, serum insulin, serum lipid profiles) and liver glyco-gen estimation. Statistical Analysis was done by using SPSS-16 software. Phytochemicals screening revealed that P. betle extract contain significant amount of tannins, flavonoids, phenols, and terpenoids. Oral consumption of P. betle showed that, a significant (P<0.01) reduction of FSG had been found when compared to the base line value. Moreover, while compared to the DWC a significant (P< 0.01) reduction of FSG has been found in P. betle treated group respectively. GT group also ameliorated FSG significantly (p<0.03) while compared to the base line value. Liver glycogen content was increased (24%) in P. betle treated rats when compared to the DWC group. Serum insulin level also increased significantly (P< 0.001) when compared to the baseline value. Furthermore, the consecutive treatment of P. betle resulted in a significant reduction of TG and Cholesterol (p<0.001 & p<0.02), a 10% decrease in LDL, and a significant increase in HDL (p<0.01). The findings of our study suggest that P. betle possesses significantly hypoglycemic and insulinomimetic properties due to the abundant sources of phytochemicals.
Article
Full-text available
Gestational diabetes mellitus (GDM) is characterized by an inadequate pancreatic β-cell response to pregnancy-induced insulin resistance, resulting in hyperglycemia. The pathophysiology involves reduced incretin hormone secretion and signaling, specifically decreased glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), impairing insulinotropic effects. Pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), impair insulin receptor substrate-1 (IRS-1) phosphorylation, disrupting insulin-mediated glucose uptake. β-cell dysfunction in GDM is associated with decreased pancreatic duodenal homeobox 1 (PDX1) expression, increased endoplasmic reticulum stress markers (CHOP, GRP78), and mitochondrial dysfunction leading to impaired ATP production and reduced glucose-stimulated insulin secretion. Excessive gestational weight gain exacerbates insulin resistance through hyperleptinemia, which downregulates insulin receptor expression via JAK/STAT signaling. Additionally, hypoadiponectinemia decreases AMP-activated protein kinase (AMPK) activation in skeletal muscle, impairing GLUT4 translocation. Placental hormones such as human placental lactogen (hPL) induce lipolysis, increasing circulating free fatty acids which activate protein kinase C, inhibiting insulin signaling. Placental 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) overactivity elevates cortisol levels, which activate glucocorticoid receptors to further reduce insulin sensitivity. GDM diagnostic thresholds (≥92 mg/dL fasting, ≥153 mg/dL post-load) are lower than type 2 diabetes to prevent fetal hyperinsulinemia and macrosomia. Management strategies focus on lifestyle modifications, including dietary carbohydrate restriction and exercise. Pharmacological interventions, such as insulin or metformin, aim to restore AMPK signaling and reduce hepatic glucose output. Emerging therapies, such as glucagon-like peptide-1 receptor (GLP-1R) agonists, show potential in improving glycemic control and reducing inflammation. A mechanistic understanding of GDM pathophysiology is essential for developing targeted therapeutic strategies to prevent both adverse pregnancy outcomes and the progression to overt diabetes in affected women.
Article
Full-text available
Biogenic synthesis of nanoparticles is one of the novel approaches for the formulation of drugs for tackling human diseases. In this study, aqueous extracts of Cola millenii were used as the reductant for the reduction of silver nitrate and synthesis of the corresponding silver nanoparticles (hereinafter designated Cm-AgNPs). The synthesis of Cm-AgNPs was verified by a color change from brown to reddish. The Cm-AgNPs were characterized by energy dispersive spectroscopy (EDS), Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), scanning electron microscopy (SEM), and X-ray diffraction (XRD). The FTIR analysis showed the presence of functional groups typical of phytochemicals that are associated with nanoparticles as capping agents. TEM and SEM analysis revealed that the CM-AgNPs were small in size and mostly spherical. About 70% of the Cm-AgNPs had a diameter of less than 20 nm. The crystalline structure of the Cm-AgNPs was confirmed by XRD analysis. In vitro studies based on 2,2-diphenyl-picrylhydrazyl (DPPH) radical inhibition and Total Antioxidant Power assays showed that the Cm-AgNPs possessed antioxidant properties. Furthermore, the Cm-AgNPs exhibited an inhibitory effect against carbohydrate hydrolyzing enzymes linked to diabetes, namely, alpha-amylase and alpha-glucosidase. Based on the results of this study, Cm-AgNPs could be potentially used for managing diabetes and other diseases in which oxidative stress is implicated in its pathology.
Article
Full-text available
The Indian Diabetes Risk Score was initially developed by the Madras Diabetes Research Foundation (MDRF-IDRS) to help detect undiagnosed Type 2 diabetes (T2DM) in the community. Soon it was found that the MDRF-IDRS could also help to predict incident diabetes, metabolic syndrome, coronary artery disease (CAD), non-alcoholic fatty liver disease as well as sleep disorders in the community. It helps to differentiate T2DM from non-T2DM. Finally, it also helps to identify those with CAD, peripheral vascular disease and neuropathy among those with T2DM. Thus, the MDRF-IDRS is a simple, virtually 'no cost' tool which is useful in several clinical and epidemiological settings.
Article
Full-text available
During the United Kingdom Prospective Diabetes Study (UKPDS), patients with type 2 diabetes mellitus who received intensive glucose therapy had a lower risk of microvascular complications than did those receiving conventional dietary therapy. We conducted post-trial monitoring to determine whether this improved glucose control persisted and whether such therapy had a long-term effect on macrovascular outcomes. Of 5102 patients with newly diagnosed type 2 diabetes, 4209 were randomly assigned to receive either conventional therapy (dietary restriction) or intensive therapy (either sulfonylurea or insulin or, in overweight patients, metformin) for glucose control. In post-trial monitoring, 3277 patients were asked to attend annual UKPDS clinics for 5 years, but no attempts were made to maintain their previously assigned therapies. Annual questionnaires were used to follow patients who were unable to attend the clinics, and all patients in years 6 to 10 were assessed through questionnaires. We examined seven prespecified aggregate clinical outcomes from the UKPDS on an intention-to-treat basis, according to previous randomization categories. Between-group differences in glycated hemoglobin levels were lost after the first year. In the sulfonylurea-insulin group, relative reductions in risk persisted at 10 years for any diabetes-related end point (9%, P=0.04) and microvascular disease (24%, P=0.001), and risk reductions for myocardial infarction (15%, P=0.01) and death from any cause (13%, P=0.007) emerged over time, as more events occurred. In the metformin group, significant risk reductions persisted for any diabetes-related end point (21%, P=0.01), myocardial infarction (33%, P=0.005), and death from any cause (27%, P=0.002). Despite an early loss of glycemic differences, a continued reduction in microvascular risk and emergent risk reductions for myocardial infarction and death from any cause were observed during 10 years of post-trial follow-up. A continued benefit after metformin therapy was evident among overweight patients. (UKPDS 80; Current Controlled Trials number, ISRCTN75451837.)
Article
Full-text available
There are virtually no epidemiological studies from India assessing the level of awareness of diabetes in a whole population. The aim of the present study was to assess the awareness of diabetes in an urban south Indian population in Chennai. The Chennai Urban Rural Epidemiology Study (CURES) is an ongoing population based study conducted using a systematic sampling method on a representative population (aged > or = 20 years - 26001 individuals) of Chennai [formerly Madras], the largest city in Southern India. A structured questionnaire was used to obtain information related to demography, education and medical history. The questionnaire included five questions on diabetes awareness. Of the total 26,001 individuals, only 75.5% (19642/26001) of the whole population reported that they knew about a condition called diabetes or conversely nearly 25% of the Chennai population was unaware of a condition called diabetes. 60.2% (15656/26001) of all participants and 76.7% (1173/1529) of the self reported diabetic subjects knew that the prevalence of diabetes was increasing in India. Only 22.2% (5764/ 26001) of the whole population and 41.0% (627/1529) of the known diabetic subjects were aware that diabetes could be prevented. Knowledge of the role of obesity and physical inactivity in producing diabetes was very low, with only 11.9% (3083/26001) of study subjects reporting these as risk factors for diabetes. Only 19.0% (4951/26001) of whole population knew that diabetes could cause complications. Even among the self reported diabetic subjects, only 40.6% (621/1529) were aware that diabetes could produce some complications. Awareness and knowledge regarding diabetes is still grossly inadequate in India. Massive diabetes education programmes are urgently needed both in urban and rural India.
Article
: The diagnosis and management of diabetes in primary care has increased immensely over the past several years. The focus of this article is on the latest substantive revisions in the diagnosis, treatment, and management of diabetes, which was presented in the January 2014 issue of the ADA's journal Diabetes Care.
Article
Preventing diabetes is of enormous value, particularly for the South Asian countries, which have a huge healthcare burden from the onslaught of the disease. Type 2 diabetes has been proved to be preventable using lifestyle changes, even in South Asians despite their heightened risk profile. Strategies to improve awareness about diabetes and translation of preventive measures by innovative, culturally specific programmes have to be implemented at national levels. Integrated involvement of the government, community, media, healthcare and education services, and financial support from national and international organizations, are required. South Asian countries have initiated national programmes for diabetes prevention and management. It is also encouraging to note that joint ventures between developed countries such as the USA, UK and other European countries and centres of excellence in South Asia have been initiated to develop large-scale, community-oriented, pragmatic intervention strategies. © 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.
Article
Prevalence of type 2 diabetes has rapidly increased in native and migrant Asian populations. Diabetes develops at a younger age in Asian populations than in white populations, hence the morbidity and mortality associated with the disease and its complications are also common in young Asian people. The young age of these populations and the high rates of cardiovascular risk factors seen in Asian people substantially increase lifetime risk of cardiovascular disease. Several distinctive features are apparent in pathogenetic factors for diabetes and their thresholds in Asian populations. The economic burden due to diabetes at personal, societal, and national levels is huge. National strategies to raise public awareness about the disease and to improve standard of care and implementation of programmes for primary prevention are urgently needed.
Article
The term prediabetes refers to subjects with impaired fasting glucose and/or impaired glucose tolerance who are at increased risk for type 2 diabetes mellitus. Although both types of patients are at increased risk for developing type 2 diabetes mellitus and cardiovascular disease, they manifest distinct metabolic abnormalities. In this article, we summarize the metabolic abnormalities that characterize each state and the contribution of these metabolic abnormalities to the increased risk of diabetes and cardiovascular disease.
Article
Simple risk scores for identifying people with undiagnosed diabetes have been developed, mostly in Caucasian groups. This may not be suitable for Asian Indians, therefore this study was undertaken to develop and validate a simple diabetes risk score in an urban Asian Indian population with a high prevalence of diabetes. We also tested whether this score was applicable to South Asian migrants living in a different cultural context. A population based Cohort of 10,003 participants aged >or=20 years was divided into two equal halves (Cohorts 1 and 2), after excluding people with known diabetes. Cohort 1 (n=4993) was used to derive the risk score. Validation of the score was performed in the other half of the survey population (Cohort 2) (n=5010). The validation was also done in a separate survey population in Chennai, India (Cohort 3) (n=2002) (diagnosis of diabetes was based on OGTT) and in the South Asian Cohort of the 1999 Health Survey for England (n=676) (fasting glucose value>or=7 mmol/l and HbA1c>or=6.5% were used for diagnosis). A logistic regression model was used to compute the beta coefficients for risk factors. The risk score value was derived from a receiver operating characteristic curve. The significant risk factors included in the risk score were age, BMI, waist circumference, family history of diabetes and sedentary physical activity. A risk score value of >21 gave a sensitivity, specificity, positive predictive value and negative predictive value of 76.6%, 59.9%, 9.4% and 97.9% in Cohort 1, 72.4%, 59%, 8.3% and 97.6% in Cohort 2 and 73.7%, 61.0%, 12.2% and 96.9% in Cohort 3, respectively. The higher distribution of risk factors in the UK Cohort means that at the same cut point the score was much more sensitive but also less specific. (sensitivity 92.2%, specificity 25.7%, positive predictive value of 21.6% and negative predictive value of 93.7%). A diabetes risk score involving simple non-biochemical measurements was developed and validated in a native Asian Indian population. This easily applicable simple score could play an important role as the first step in the process of identifying individuals with an increased likelihood of having prevalent but undiagnosed diabetes. The different distribution of risk factors with the migrant Asian Indians living in England and the different relationship between sensitivity and specificity for the same score demonstrate that risk scores and cut-points developed and tested even within one ethnic group cannot be generalized to individuals of the same ethnic group living in a different cultural setting where the distribution of risk factors for diabetes is different.